The COVID-19 pandemic and its impact on the development of gestational diabetes mellitus (GDM) in West Virginia

Diabetes Res Clin Pract. 2024 Feb:208:111126. doi: 10.1016/j.diabres.2024.111126. Epub 2024 Feb 2.

Abstract

Objective: To examine the rate of gestational diabetes mellitus (GDM) prevalence before and during the COVID-19 pandemic.

Results: Analysis revealed that GDM prevalence was significantly higher during the COVID-19 pandemic compared to pre-pandemic (8.59 % vs 7.77 %). The risk of GDM was 12 % higher during the pandemic vs. pre-pandemic (aRR = 1.12, 95 % CI 1.06, 1.19) and the aRD = 0.95 % (95 % CI 0.56 %, 1.33 %) adjusting for maternal age and substance use in pregnancy.

Conclusions: GDM rates in WV increased from the period directly before the COVID-19 pandemic to during the COVID-19 pandemic. More research is needed to understand the pathophysiological mechanisms of pandemics and pandemic-related risk factors for this observed association. Supporting pregnant individuals during such events is critical to both maternal and child health.

Keywords: Appalachia; Coronavirus; Covid-19; Gestational Diabetes; West Virginia.

MeSH terms

  • COVID-19* / epidemiology
  • Child
  • Diabetes, Gestational* / epidemiology
  • Female
  • Humans
  • Pandemics
  • Pregnancy
  • Risk Factors
  • West Virginia / epidemiology